Product Images Butorphanol Tartrate

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 11 images provide visual information about the product associated with Butorphanol Tartrate NDC 60505-0813 by Apotex Corp., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Figure1.jpg - Figure1

Figure1.jpg - Figure1

Figure2.jpg - Figure2

Figure2.jpg - Figure2

Figure3.jpg - Figure3

Figure3.jpg - Figure3

Figure4.jpg - Figure4

Figure4.jpg - Figure4

Figure5.jpg - Figure5

Figure5.jpg - Figure5

Figure6.jpg - Figure6

Figure6.jpg - Figure6

Figure7.jpg - Figure7

Figure7.jpg - Figure7

btl-lbl-2.5mL.jpg - btl lbl 2.5mL

btl-lbl-2.5mL.jpg - btl lbl 2.5mL

This is a medication description for a nasal spray called Butorphanol Tartrate. The nasal spray comes in a 2.5mL bottle and is meant for nasal use only. Each milliliter of the spray contains 10mg of Butorphanol Tartrate. The manufacturer is Apotex Inc. based in Toronto, Ontario. The medication should be stored at a temperature range of 20°C to 25°C (68°F to 77°F) as per USP Controlled Room Temperature guidelines. The NDC number for the medication is 60505-0813-1.*

figure.jpg - figure

figure.jpg - figure

This appears to be a graph with two lines showing plasma concentration in nanograms per milliliter over time (in hours) for two different groups (one with IV treatment and one with NS treatment). However, the graph is not readable and needs to be properly formatted to extract meaningful information.*

structure.jpg - structure

structure.jpg - structure

symbol.jpg - symbol

symbol.jpg - symbol

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.